
South Africa


April 2022: Single-dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis
Article and Study Summary: Single-dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis Published in: New England Journal of Medicine 2022;386(12):1109-1120 https://www.nejm.org/doi/full/10.1056/NEJMoa2111904 Authors: Jarvis JN, Lawrence DS, Meya DB, et...Women’s Perceptions Of HIV- And Sexuality-Related Stigma in Relation to Prep: Qualitative Findings from The Masibambane Study, Durban, South Africa
Authors: S Bergam, A D Harrison, N Benghu, S Khumalo, N Tesfay, T Exner, L Miller, C Dolezal, J Hanass-Hancock, S Hoffman Daily oral pre-exposure prophylaxis (PrEP) offers effective HIV prevention. In South Africa, PrEP is publicly available, but use among young women...
February 2022: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children
Article and Study Summary: Dolutegravir as First- or Second-line Treatment for HIV-1 Infection in Children Published in: New England Journal of Medicine 2021,385(27):2531-2543. https://www.nejm.org/doi/full/10.1056/NEJMoa2108793 Authors: Turkova A, White E, Mujuru HA,...